Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

ClinicalTrials.gov ID: NCT00449527

Public ClinicalTrials.gov record NCT00449527. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 2:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Two-week, Randomised, Double-blind Study Assessing the Onset of Effect Questionnaire Administered Daily Versus Weekly in Adult Subjects (≥ 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT® pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Actuations Twice Daily

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to demonstrate whether subjects respond similarly to the Onset of Effect Questionnaire (OEQ) using a 1 week recall period versus a 1 day recall period.

Study identification

NCT ID
NCT00449527
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
123 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
Not listed
Completion
Aug 2007 (Actual)
Last update posted
Jan 24, 2011

2007

United States locations

U.S. sites
44
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Research Site Tuscumbia Alabama — —
Research Site Fort Smith Arkansas — —
Research Site Long Beach California — —
Research Site Orange California — —
Research Site Riverside California — —
Research Site Sacramento California — —
Research Site San Diego California — —
Research Site San Jose California — —
Research Site Colorado Springs Colorado — —
Research Site Denver Colorado — —
Research Site Valrico Florida — —
Research Site River Forest Illinois — —
Research Site Council Bluffs Iowa — —
Research Site Topeka Kansas — —
Research Site Wichita Kansas — —
Research Site Bowling Green Kentucky — —
Research Site Florence Kentucky — —
Research Site Metairie Louisiana — —
Research Site City of Saint Peters Missouri — —
Research Site St Louis Missouri — —
Research Site Butte Montana — —
Research Site Omaha Nebraska — —
Research Site Papillion Nebraska — —
Research Site Las Vegas Nevada — —
Research Site Skillman New Jersey — —
Research Site Summit New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site New York New York — —
Research Site North Syracuse New York — —
Research Site Rochester New York — —
Research Site Greensboro North Carolina — —
Research Site Mooresville North Carolina — —
Research Site Oklahoma City Oklahoma — —
Research Site Tulsa Oklahoma — —
Research Site Collegeville Pennsylvania — —
Research Site Charleston South Carolina — —
Research Site Greenville South Carolina — —
Research Site Spartanburg South Carolina — —
Research Site Union South Carolina — —
Research Site Dallas Texas — —
Research Site South Burlington Vermont — —
Research Site Bellingham Washington — —
Research Site Spokane Washington — —
Research Site Tacoma Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00449527, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2011 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00449527 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →